118 related articles for article (PubMed ID: 14695168)
1. Activating transcription factor 4 increases the cisplatin resistance of human cancer cell lines.
Tanabe M; Izumi H; Ise T; Higuchi S; Yamori T; Yasumoto K; Kohno K
Cancer Res; 2003 Dec; 63(24):8592-5. PubMed ID: 14695168
[TBL] [Abstract][Full Text] [Related]
2. Clock and ATF4 transcription system regulates drug resistance in human cancer cell lines.
Igarashi T; Izumi H; Uchiumi T; Nishio K; Arao T; Tanabe M; Uramoto H; Sugio K; Yasumoto K; Sasaguri Y; Wang KY; Otsuji Y; Kohno K
Oncogene; 2007 Jul; 26(33):4749-60. PubMed ID: 17297441
[TBL] [Abstract][Full Text] [Related]
3. [Effect of cisplatin on the expression of Pokemon gene: experiment with different human lung cancer cells].
Zhao ZH; Wang SF; Yu L; Wang J; Cong DG; Chang H; Wang XF; Zhang TW; Zhang J; Fu K; Jiang JY
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1211-3. PubMed ID: 18844119
[TBL] [Abstract][Full Text] [Related]
4. Novel mechanisms of platinum drug resistance identified in cells selected for resistance to JM118 the active metabolite of satraplatin.
Samimi G; Kishimoto S; Manorek G; Breaux JK; Howell SB
Cancer Chemother Pharmacol; 2007 Feb; 59(3):301-12. PubMed ID: 16770583
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J
Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342
[TBL] [Abstract][Full Text] [Related]
6. Genetic and expression profiles of squamous cell carcinoma of the head and neck correlate with cisplatin sensitivity and resistance in cell lines and patients.
Akervall J; Guo X; Qian CN; Schoumans J; Leeser B; Kort E; Cole A; Resau J; Bradford C; Carey T; Wennerberg J; Anderson H; Tennvall J; Teh BT
Clin Cancer Res; 2004 Dec; 10(24):8204-13. PubMed ID: 15623595
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of constitutive signal transducer and activator of transcription 3 mRNA in cisplatin-resistant human non-small cell lung cancer cells.
Ikuta K; Takemura K; Kihara M; Nishimura M; Ueda N; Naito S; Lee E; Shimizu E; Yamauchi A
Oncol Rep; 2005 Feb; 13(2):217-22. PubMed ID: 15643501
[TBL] [Abstract][Full Text] [Related]
8. [Cisplatin sensitivity transcriptional factor and mitochondrial DNA maintenance protein].
Uchiumi T; Knag D
Rinsho Byori; 2009 Oct; 57(10):978-86. PubMed ID: 19928495
[TBL] [Abstract][Full Text] [Related]
9. Concentration-dependent collateral sensitivity of cisplatin-resistant gastric cancer cell sublines.
Xu H; Choi SM; An CS; Min YD; Kim KC; Kim KJ; Choi CH
Biochem Biophys Res Commun; 2005 Mar; 328(2):618-22. PubMed ID: 15694393
[TBL] [Abstract][Full Text] [Related]
10. Gene expression signature of human cancer cell lines treated with the ras inhibitor salirasib (S-farnesylthiosalicylic acid).
Blum R; Elkon R; Yaari S; Zundelevich A; Jacob-Hirsch J; Rechavi G; Shamir R; Kloog Y
Cancer Res; 2007 Apr; 67(7):3320-8. PubMed ID: 17409441
[TBL] [Abstract][Full Text] [Related]
11. AKT1 amplification regulates cisplatin resistance in human lung cancer cells through the mammalian target of rapamycin/p70S6K1 pathway.
Liu LZ; Zhou XD; Qian G; Shi X; Fang J; Jiang BH
Cancer Res; 2007 Jul; 67(13):6325-32. PubMed ID: 17616691
[TBL] [Abstract][Full Text] [Related]
12. [Enhancement effect of nucleotide excision repair gene xeroderma pigmentosun group a antisense RNA on sensitivity of human lung adenocarcinoma cell line A549 to cisplatin].
Fan W; Zhang HL; Wu XM
Ai Zheng; 2005 Apr; 24(4):403-7. PubMed ID: 15820060
[TBL] [Abstract][Full Text] [Related]
13. Altered ErbB receptor signaling and gene expression in cisplatin-resistant ovarian cancer.
Macleod K; Mullen P; Sewell J; Rabiasz G; Lawrie S; Miller E; Smyth JF; Langdon SP
Cancer Res; 2005 Aug; 65(15):6789-800. PubMed ID: 16061661
[TBL] [Abstract][Full Text] [Related]
14. [Study on the expression of DNA excision repair biomarkers in cispatin-treated lung cancer cell line].
Wang ZY; Zhou S; Lu B; Zhang X; Hao QL; Zhou YK
Zhonghua Yu Fang Yi Xue Za Zhi; 2003 Mar; 37(2):109-11. PubMed ID: 12839662
[TBL] [Abstract][Full Text] [Related]
15. Enhanced expression of PCAF endows apoptosis resistance in cisplatin-resistant cells.
Hirano G; Izumi H; Kidani A; Yasuniwa Y; Han B; Kusaba H; Akashi K; Kuwano M; Kohno K
Mol Cancer Res; 2010 Jun; 8(6):864-72. PubMed ID: 20530585
[TBL] [Abstract][Full Text] [Related]
16. Codominance of cisplatin resistance in somatic cell hybrids.
Ying YL; Shen DW; Liang XJ; Gottesman MM
J Cell Physiol; 2003 Jul; 196(1):63-9. PubMed ID: 12767041
[TBL] [Abstract][Full Text] [Related]
17. Inositol 1,4,5-trisphosphate (IP3) receptor type1 (IP3R1) modulates the acquisition of cisplatin resistance in bladder cancer cell lines.
Tsunoda T; Koga H; Yokomizo A; Tatsugami K; Eto M; Inokuchi J; Hirata A; Masuda K; Okumura K; Naito S
Oncogene; 2005 Feb; 24(8):1396-402. PubMed ID: 15608674
[TBL] [Abstract][Full Text] [Related]
18. Altered cell-cell adhesion in cisplatin-resistant human carcinoma cells: a link between beta-catenin/plakoglobin ratio and cisplatin resistance.
Cimbora-Zovko T; Ambriović-Ristov A; Loncarek J; Osmak M
Eur J Pharmacol; 2007 Mar; 558(1-3):27-36. PubMed ID: 17234182
[TBL] [Abstract][Full Text] [Related]
19. The modifier subunit of glutamate cysteine ligase relates to cisplatin resistance in human small cell lung cancer xenografts in vivo.
Nishi M; Abe Y; Fujimori S; Hamamoto A; Inoue Y; Miyazaki N; Oida Y; Ikoma N; Ohnishi Y; Yamazaki H; Ueyama Y; Nakamura M
Oncol Rep; 2005 Aug; 14(2):421-4. PubMed ID: 16012725
[TBL] [Abstract][Full Text] [Related]
20. [RNA interference silencing excision repair cross-complementing 1 gene and affecting cisplatin sensitivity on lung cancer cell lines].
Shang XB; Yu ZT; Tang P; Zhang XZ
Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(39):2799-802. PubMed ID: 19080461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
